UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026386
Receipt number R000030317
Scientific Title Effects of Gadobutrol on background parenchymal enhancement in breast dynamic MRI
Date of disclosure of the study information 2017/03/06
Last modified on 2022/09/12 14:07:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of Gadobutrol on background parenchymal enhancement in breast dynamic MRI

Acronym

Effects of Gadobutrol on background parenchymal enhancement in breast dynamic MRI

Scientific Title

Effects of Gadobutrol on background parenchymal enhancement in breast dynamic MRI

Scientific Title:Acronym

Effects of Gadobutrol on background parenchymal enhancement in breast dynamic MRI

Region

Japan


Condition

Condition

Patients who are scheduled to undergo breast dynamic MRI for breast cancer or suspected breast cancer

Classification by specialty

Breast surgery Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To determine the effect of background parenchymal enhancement on contrast during the early phase of breast dynamic MRI using background

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

To determine the effect of background parenchymal enhancement on contrast during the early phase of breast dynamic MRI using background
: lesion-to-background contrast with gadobutrol will be compared with the large-scale data

Key secondary outcomes

To characterize the TIC of gadobutrol-enhanced breast dynamic MRI : The TIC will be compared with previous reports and discussed


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >

Gender

Female

Key inclusion criteria

-Patients who are scheduled to undergo breast MRI for breast cancer or suspected breast cancer
-Patients aged 20 to less than 70 years
-Patients with information on menstrual cycles available, if premenopausal
-Both the inpatient and outpatient settings are acceptable

Key exclusion criteria

-Patients with known hypersensitivity to gadolinium-based contrast agents
-Patients with renal impairment (e-GFR : less than 30mL/min/1.73m2)
-Pregnant, Parturient or breastfeeding women
-Patients who experienced breast cancer in the past, with invasive treatment
-Patients receiving drug therapy for breast cancer
-Patients who are inappropriate for enrolment for any other reason in the opinion of the investigator

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Mitsuhiro
Middle name
Last name Tozaki

Organization

Sagara hospital

Division name

Radiology

Zip code

892-0833

Address

3-31 Shinyashiki-cho, Kagoshima City

TEL

099-224-1800

Email

tozaki@sagara.or.jp


Public contact

Name of contact person

1st name Ikumi
Middle name
Last name Waki

Organization

Hakuaikai Social Medical Corporation Sagara Hospital

Division name

Clinical Research Center

Zip code

892-0833

Address

3-31 Shinyashiki-cho, Kagoshima City

TEL

099-224-1800

Homepage URL


Email

i-waki1031@sagara.or.jp


Sponsor or person

Institute

Sagara hospital

Institute

Department

Personal name



Funding Source

Organization

Bayer Yakuhin

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Social medical corporation Hakuaikai Sagara Hospital Institutional Review Board

Address

3-31 Shinyashiki-cho, Kagoshima City

Tel

099-224-1823

Email

i-waki1031@sagara.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

相良病院(鹿児島県)、東京医科歯科大学(東京都)、京都府立医科大学(京都府)、九州大学(福岡県)、ブレストピア宮崎病院(宮崎県)/ Sagara hospital (Kagoshima Pref.), Tokyo medical and dental Univ. (Tokyo), Kyoto prefectural University of medicine (Kyoto), Kyushu Univ. (Fukuoka Pref.),Breastopia Miyazaki hospital (Miyazaki Pref.)


Other administrative information

Date of disclosure of the study information

2017 Year 03 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 02 Month 01 Day

Date of IRB

2017 Year 01 Month 17 Day

Anticipated trial start date

2017 Year 04 Month 01 Day

Last follow-up date

2018 Year 07 Month 31 Day

Date of closure to data entry

2019 Year 01 Month 31 Day

Date trial data considered complete

2019 Year 01 Month 31 Day

Date analysis concluded

2020 Year 01 Month 31 Day


Other

Other related information

The purpose of this study is to evaluate major evaluation items descriptively, to compare them with past study, and does not set statistical case based on main evaluation item


Management information

Registered date

2017 Year 03 Month 03 Day

Last modified on

2022 Year 09 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030317


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name